Cue Health Inc. (HLTH)
| Market Cap | 23.23M |
| Revenue (ttm) | 70.94M |
| Net Income (ttm) | -373.46M |
| Shares Out | 159.09M |
| EPS (ttm) | -2.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 247,126 |
| Open | 0.153 |
| Previous Close | 0.150 |
| Day's Range | 0.142 - 0.156 |
| 52-Week Range | 0.132 - 0.988 |
| Beta | 1.22 |
| Analysts | Hold |
| Price Target | 0.50 (+242.47%) |
| Earnings Date | May 8, 2024 |
About HLTH
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, C... [Read more]
Financial Performance
In 2023, Cue Health's revenue was $70.94 million, a decrease of -85.33% compared to the previous year's $483.48 million. Losses were -$373.46 million, 92.5% more than in 2022.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for HLTH stock is "Hold." The 12-month stock price forecast is $0.5, which is an increase of 242.47% from the latest price.
News
Cue Health Announces Strategic Actions to Position Company for Next Stage
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the “Boar...
Cue Health Reports Fourth Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2023. Recent...
Cue Health to Announce Fourth Quarter and Full Year 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full year 2023 financial results on Wed...
Cue Health Announces Appointment of Rishi Reddy to Board of Directors
SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced it entered into a cooperation agreement (the “Cooperation Agreement”) with Tarsadia Investments ...
Cue Health to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will participate at the BTIG MedTech, Digital Health, Life Scie...
Cue Health Reports Third Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the third quarter 2023. Recent Highlights Reported third quart...
Cue Health to Announce Third Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its third quarter 2023 financial results on Wednesday, Novembe...
Concerned Stockholders of Cue Health Send Letter to Board
LOS ANGELES--(BUSINESS WIRE)--Kelly Day and other concerned stockholders sent a letter to the board of directors of Cue Health outlining their urgent concerns for the Company.
Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health's Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test
SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, announced today the peer-reviewed publication of an independent clinical study - the largest of its kind on asym...
Cue Health Adopts Limited-Duration Shareholder Rights Plan
SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration sharehol...
Tarsadia Investments Sends Letter to Board of Cue Health, Inc.
NEW YORK--(BUSINESS WIRE)--Tarsadia Investments, LLC (“Tarsadia”) represents long-term stockholders of Cue Health, Inc. (the “Company” or “Cue”) (NASDAQ: HLTH), with holdings that collectively make th...
Cue Health to Present at Upcoming Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the following investor conferences: 2023 Wells ...
Cue Health Reports Second Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the second quarter 2023. Recent Highlights Reported second qua...
Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use
SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced Res...
Cue Health to Announce Second Quarter 2023 Financial Results
SAN DIEGO, Calif.--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its second quarter 2023 financial results on Wednesday...
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, announces an industry breakthrough as the first company to receive De Novo authorization from the U.S. Food and ...
US FDA approves Cue Health's at-home COVID test
The U.S. Food and Drug Administration on Tuesday approved Cue Health's at-home COVID-19 test, the first coronavirus test to get marketing authorization using a traditional premarket review, the agency...
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
SAN DIEGO, Calif.--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the Goldman Sachs 44th Annual Global He...
Cue Health Reports First Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the first quarter 2023. Recent Highlights Reported first quart...
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration (FDA) for...
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced an expansion of its Cue Integrated Care Platform to include a new pharmacy offering with...
Cue Health to Announce First Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2023 financial results on Wednesday, May 10,...
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 26, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cue Health Inc. ...
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)---- $HLTH #HLTH--The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm.
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)---- $HLTH #HLTH--The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm.